Sharechat Logo

Energy Mad on the block as board mulls firm's future

Tuesday 14th March 2017

Text too small?

Energy Mad, the energy efficient light bulb maker and marketer, is up for sale as the company's board weighs up the future of the business.

The Christchurch-based company sought a trading halt on its shares yesterday, and today said the board is "currently pursuing a potential sale of the business" among "various options for the future of the company". A sale would need shareholder approval, meaning it would have to convince NZX-owned fund manager SuperLife, which swapped 2.25 million convertible notes for shares last month lifting its stake to 71.4 percent.

"Energy Mad will make an announcement in the short term regarding this sale if it is to proceed," it said in a statement.

The company has struggled to make ends meet since listing on the NZX in 2011 and has relied on funding lines from SuperLife to keep operating.

Energy Mad lifted operating revenue 48 percent to $3.7 million in the six months ended Sept. 30 and its first-half operating loss shrank to $200,000 from $500,000 a year earlier.

The trading halt on the shares was lifted after the announcement. The stock last traded at 2.4 cents apiece, valuing the firm at $1.9 million. It raised $5 million selling shares for $1 each in its 2011 initial public offering.



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZ dollar eases on technical factors, buoyed by higher dairy prices
RBNZ eyes Westpac Australia money laundering failures
Heritage buys Golden Healthcare; not mystery Metlife suitor
Alliance margins improve as swine fever boosts global meat prices
RBNZ eyes Westpac Australia money laundering failures
Precinct eyes new developments as Commercial Bay keeps to revised schedule
End to Tower's three year dividend drought in sight
Vital Healthcare's manager appoints new independent director
Argosy lifts first-half profit 15.2% on valuation gains
Metlifecare attracts 'credible' bidder after biggest trading day in 2 1/2 years

IRG See IRG research reports